Novel Diabetes Drug Lowers Blood Pressure

ASH 2012 — NEW YORK CITY — An investigational glucagon-like peptide-1 agonist significantly reduced systolic blood pressure in patients with type 2 diabetes who were taking oral anti-hyperglycemic medications, a phase II trial showed.


< Back to Listings